The Current and Future Burden and Cost of Overactive Bladder in Five European Countries

European Urology

Volumn 50, Issue 5, 2006, Pages 1050-1057

  Reeves, Penny ^a   Irwin, Deb ^b   Kelleher, Con ^c   Milsom, Ian ^d   Kopp, Zoe ^e   Calvert, Neill ^a   Lloyd, Adam ^a  

^a Fourth Hurdle Consulting Ltd   (United Kingdom)

^b IL   (United States)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e PFIZER INC   (United States)

Author keywords

Burden; Cost of illness; Overactive bladder

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; EUROPE; FEMALE; GERMANY; HEALTH CARE SYSTEM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; SPAIN; SWEDEN; UNITED KINGDOM;

ADULT; AGED; COSTS AND COST ANALYSIS; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER, OVERACTIVE;

EID: 33749240589     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.04.018     Document Type: Article

References (44)

1. Ekelund P., Grimby A., and Milsom I. Urinary incontinence. Social and financial costs high. BMJ 306 (1993) 1344
2. Hu T.W. Impact of urinary incontinence on health-care costs. J Am Geriatr Soc 38 (1990) 292-295
3. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report for the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167-178
4. Milsom I., Abrams P., Cardoza L., Roberts R.G., Thuroff J., and Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87 (2001) 760-766
5. Stewart W., Van Rooyen J., Cundiff G., Abrams P., Herzog A., Corey R., Hunt T., and Wein A. Prevalence of OAB in the US. World J Urol 20 (2003) 327-336
6. Abrams P., Kelleher C.J., Kerr L.A., and Rogers R.G. Overactive bladder significantly affects quality of life. Am J Manag Care 6 (2000) S580-S590
7. Ouslander J.G., Shih Y.T., Malone-Lee J., and Luber K. Overactive bladder: special considerations in the geriatric population. Am J Manag Care 6 (2000) S599-S606
8. Brown J.S., Vittinghoff E., Wyman J.F., et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 48 (2000) 721-725
9. Freeman R, Bridge S, Dooley JA. Falls and overactive bladder: the need for a prevention strategy. Presented at ISPE (International Society for Pharmacoepidemiology), August 2004.
10. Tromp A.M., Pluijm S.M., Smit J.H., Deeg D.J., Bouter L.M., and Lips P. Fall-Risk Screening Test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54 (2001) 837-844
11. Hu T.W., and Wagner T.H. Economic considerations in overactive bladder. Am J Manag Care 6 (2000) S591-S598
12. Hu T.W., Wagner T.H., Bentkover J.D., et al. Estimated economic costs of overactive bladder in the United States. Urology 61 (2003) 1123-1128
13. Hu T.W., Wagner T.H., Bentkover J.D., LeBlanc K., Zhou S.Z., and Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63 (2004) 461-465
14. Wagner T.H., Hu T.W., Bentkover J., et al. Health-related consequences of overactive bladder. Am J Manag Care 8 (2002) S598-S607
15. Bodden-Heidrich R., Beckmann M.W., Libera B., Rechenberger I., and Bender H.G. Psychosomatic aspects of urinary incontinence. Arch Gynecol Obstet 262 (1999) 151-158
16. Zorn B.H., Montgomery H., Pieper K., Gray M., and Steers W.D. Urinary incontinence and depression. J Urol 102 (1999) 82-84
17. Getsios D., El Hadi W., Caro I., and Caro J.J. Pharmacological management of overactive bladder: a systematic and critical review of published economic evaluations. Pharmacoeconomics 23 (2005) 995-1006
18. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World population prospects: the 2002 revision. http://esa.un.org/unpp. Accessed May 7, 2004.
19. Irwin D., Milsom I., Kopp Z., et al. Overactive bladder symptom prevalence and healthcare-seeking behavior among men in 6 European countries. Eur Urol Suppl 4 3 (2005) 60
20. Mediplus (IMS Health), Institute of Medical Statistics, Frankfurt, Germany, 2001.
21. Brocklehurst J.C. Urinary incontinence in the community-analysis of a MORI poll. BMJ 306 (1993) 832-834
22. Berto P. Qualità della vita e cost-of-illness dell'incontinenza urinaria femminile: i risultati di uno studio italiano. 2002. Report no. 2.
23. Martinez J. Estudio de concordancia entre el diagnostico clinico de incontinencia de orina en la mujer realiizadp en una unidad de suelo pelviano de un programa de atencion a la mujer de atencion primaria y el diagnostico urodinamico. 2003. 4-8-0004.
24. Rentzhog L, Hellstrom AL, Kinn AC, et al. Evidence based treatment of urinary incontinence; Swedish Council on Technology Assessment in Healthcare. 2000. Report no. 143.
25. Wagner T.H., and Hu T.W. Economic costs of urinary incontinence in. Urology 51 (1998) 355-361
26. Brown J.S., Vittinghoff E., Wyman J.F., et al. Urinary incontinence: does it increase risk for falls and fractures?. J Am Geriatr Soc 48 (2000) 721-725
27. Dallosso H.M., McGrother C.W., Matthews R.J., and Donaldson M.M.K. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 92 (2003) 69-77
28. Stewart W., Van Rooyen J.B., Cundiff G.W., et al. Prevalence and burden of overactive bladder in the US. World J Urol 20 (2003) 327-336
29. Zhous Z., Jenson G., Barr C., and Torigoe Y. Antidepressant use and treatment of overactive bladder disorder. J Urol 13 (2001) 7-16
30. Doran C., Chiarelli P., and Cockburn J. Economic costs of urinary incontinence in community-dwelling Australian women. Med J Aust 174 (2001) 456-458
31. Ricci J.A., Baggish J.S., Hunt T.L., et al. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther 23 (2001) 1245-1259
32. Kornides M., and Moore K. Per capita use of continence pads in 12 countries in relation to per capita gross domestic product. Aust Cont J 5 (1999) 136-137
33. Cornago D., and Garattini L. The reimbursable incontinence pads market for outpatients in five European countries: a comparative analysis. Health Econ Prevent Care 2 (2001) 86-90
34. Kelleher CJ. Introduction to the forum and overview of epidemiology. Presentation at 6th European Interactive Forum-Key Issues and New Concepts in Overactive Bladder, 2003.
35. Josephson K., and Ginsberg D.A. Key considerations when treating the older patient with symptoms of urinary frequency and urgency. Ann Long Term Care 12 (2004) 25-32
36. Fultz N., Girts T., Kinchen K., Nygaard I., Pohl G., and Sternfeld B. Prevalence, management and impact of urinary incontinence in the workplace. Occup Med (Lond) 55 (2005) 552-557
37. Abrams P., and Swift S. Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol 48 (2005) 483-487
38. Chapple C., Khullar V., Gabriel Z., and Dooley J.A. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48 (2005) 5-26
39. Chapple C.R., Martinez-Garcia R., Selvaggi L., et al. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48 (2005) 464-470
40. 3 selective receptor antagonist. Eur Urol 48 (2005) 471-477
41. Lucioni G. IL costo sociale del diabete di tipo 2 in Italia: l studio CODE-2. Pharmacoeconomics 2 (2000) 1-21
42. Curtis L, Netten A. Unit Costs of Health and Social Care, Personal Social Services Research Unit (PSSRU), Canterbury, 2004.
43. Henriksson F., Fredrikson S., Masterman T., and Jönsson B. Costs, quality of life and disease severity in multiple sclerosis: a cross sectional study in Sweden. Eur J Neurol 8 (2001) 26-35
44. http://www.benefitsnowshop.co.uk, accessed May 2004.